Physician profile
Javier Alonso
NPI 1194772160
$17,356.83
in general payments reported to CMS, 2019-2025
10 companies · $448 in 2025
The $448 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,450 · 2020: $98.53 · 2021: $3,584 · 2022: $7,484 · 2023: $442 · 2024: $3,851 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,750 · Food and Beverage: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,750.00 |
| Food and Beverage | $990.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $10,518.65 | 2021-2022 | |
| Abbvie INC. | $4,058.93 | 2023-2025 | Botox |
| Merz North America, INC. | $808.73 | 2019-2025 | |
| Vascular Solutions, INC. | $730.00 | 2019 | |
| Boston Scientific Corporation | $562.34 | 2022-2025 | Varithena Administration Pack |
| Leo Pharma INC. | $194.17 | 2022-2025 | Adbry |
| Galderma Laboratories, L.P. | $191.26 | 2020-2023 | |
| Tactile Systems Technology INC | $149.21 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Novo Nordisk INC | $122.91 | 2023 | Wegovy |
| Teva Pharmaceuticals USA, INC. | $20.63 | 2025 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javier Alonso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.